Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Enimmune corporation (6564) Financial Statements

Enimmune corporation Financial Overview

Enimmune corporation's market cap is currently NT$1.22B. The company's EPS TTM is NT$-1.68; its P/E ratio is -8.87; Enimmune corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 48.19MNT$ 39.91MNT$ 43.49MNT$ 188.41MNT$ 109.82M
Gross ProfitNT$ 8.02MNT$ 14.23MNT$ -23.37MNT$ 20.84MNT$ 38.72M
Operating IncomeNT$ -185.24MNT$ -151.29MNT$ -243.47MNT$ -286.42MNT$ -58.67M
EBITDANT$ -176.17MNT$ -155.78MNT$ -228.96MNT$ -258.42MNT$ -38.40M
Net IncomeNT$ -164.54MNT$ -157.55MNT$ -223.74MNT$ -247.96MNT$ -47.25M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 246.79MNT$ 504.81MNT$ 379.80MNT$ 502.08MNT$ 349.79M
Total AssetsNT$ 456.10MNT$ 723.70MNT$ 604.83MNT$ 775.09MNT$ 610.07M
Total DebtNT$ 171.19MNT$ 107.86MNT$ 45.73MNT$ 29.69MNT$ 8.08M
Net DebtNT$ -31.19MNT$ -377.04MNT$ -314.16MNT$ -364.48MNT$ -110.30M
Total LiabilitiesNT$ 306.41MNT$ 244.49MNT$ 173.46MNT$ 109.68MNT$ 40.04M
Stockholders' EquityNT$ 149.69MNT$ 374.06MNT$ 321.95MNT$ 544.54MNT$ 570.03M
Cash Flow
Free Cash FlowNT$ -147.69MNT$ -144.25MNT$ -138.13MNT$ -200.98MNT$ -74.96M
Operating Cash FlowNT$ -143.51MNT$ -143.78MNT$ -138.13MNT$ -200.64MNT$ -71.55M
Investing Cash FlowNT$ -182.06MNT$ -3.64MNT$ 87.86MNT$ 99.94MNT$ 90.10M
Financing Cash FlowNT$ 53.47MNT$ 264.09MNT$ 16.03MNT$ 381.08MNT$ -3.94M

Currency in TWD

Enimmune corporation Earnings and Revenue History

-500M-250M0250M-12000 %-8000 %-4000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Enimmune corporation Liabilities to Assets

0300M600M900M0 %25 %50 %75 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Enimmune corporation Cash Flow

-400M-200M0200M400M600M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Enimmune corporation Forecast EPS vs Actual EPS

Earnings >